A meta-analysis of the therapeutic effects of tumor necrosis factor-α blockers on ulcerative colitis-Reference-Cited by-同舟云学术

A meta-analysis of the therapeutic effects of tumor necrosis factor-α blockers on ulcerative colitis

Published:2011-06-21 Issue:8 Volume:67 Page:759-766
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Huang Xuan,Lv Bin,Jin Hai-feng,Zhang Shuo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-011-1079-3.pdf

Reference32 articles.

1. Lakatos PL (2006) Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 12:6102–6108

2. Kornbluth A, Sachar DB (2004) Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 99:1371–1385

3. Carter MJ, Lobo AJ, Travis SP (2004) Guidelines for the management of inflammatory bowel disease in adults. Gut 53(Suppl 5):V1–V16

4. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT (1993) Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 34:1705–1709

5. Rahimi R, Nikfar S, Abdollahi M (2007) Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids. Med Sci Monit 13:I13–I118

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lactoferrin as a Component of Pharmaceutical Preparations: An Experimental Focus;Pharmaceuticals;2023-01-31

2. Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system;PLOS ONE;2019-12-04

3. Efficacy and safety of biologic agents and tofacitinib in moderate‐to‐severe ulcerative colitis: A systematic overview of meta‐analyses;United European Gastroenterology Journal;2019-12

4. Mechanisms of action of molecules with anti-TNF-alpha activity on intestinal barrier inflammation;Medicine;2019-09

5. Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review;Autoimmunity Reviews;2019-05